Essential Access Health Awarded $21 Million to Lead California’s Title X Family Planning Program
FOR IMMEDIATE RELEASE
March 29, 2019
Contact: Amy Moy, email@example.com, 415.518.4465
Essential Access Health was awarded $21 million today by the Department of Health and Human Services to administer California’s Title X family planning program. Essential Access has led the statewide Title X program since it was established by Congress in 1970.
California is home to the largest and most comprehensive Title X system in the nation, with one out of every four Title X patients residing in the state. Title X funding supports the delivery of quality sexual and reproductive services such as birth control, breast and cervical cancer screenings, STD testing and treatment at more than 350 health centers in 38 California counties, that collectively serve 1,000,000 women, men, and teens each year.
“We are pleased that Essential Access Health has, once again, been awarded a statewide Title X grant to lead California’s family planning program,” said Julie Rabinovitz, President and CEO of Essential Access Health. “With this grant, Essential Access will continue to do what we’ve done since the beginning of the Title X program, support the delivery of quality sexual and reproductive health care to 1 million low-income Californians each year.”
California’s Title X program has been a critical part of the state’s success in reducing unintended pregnancy rates over the past three decades. While Essential Access Health looks forward to building upon that progress, there is also concern that recent policies by the Trump administration have opened the Title X program to entities that do not offer a broad range of medically-approved birth control methods, which is foundational to the program’s success.
“We were funded for $23,150,000 for the past 12 months and we are receiving $21 million for the next 12 months,” Rabinovitz said. “Diverting this critical funding to crisis pregnancy centers like Obria puts patients at risk for unintended pregnancy, could delay access to time-sensitive services, deny women information about all of their health care options, and threaten quality of care.”